PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.
- DOI
- 10.1007/s11306-025-02226-2
- Published
- 2025 Mar 10
- Container
- Metabolomics : Official journal of the Metabolomic Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11306-025-02226-2,
title = {PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.},
author = {Sun J and Dahboul F and Pujos-Guillot E and Petera M and Chu-Van E and Colsch B and Weil D and Di Martino V and Demidem A and Abergel A},
year = {2025},
journal = {Metabolomics : Official journal of the Metabolomic Society},
doi = {10.1007/s11306-025-02226-2},
url = {https://doi.org/10.1007/s11306-025-02226-2}
}RIS
TY - JOUR TI - PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis. AU - Sun J AU - Dahboul F AU - Pujos-Guillot E AU - Petera M AU - Chu-Van E AU - Colsch B AU - Weil D AU - Di Martino V AU - Demidem A AU - Abergel A PY - 2025 JO - Metabolomics : Official journal of the Metabolomic Society DO - 10.1007/s11306-025-02226-2 UR - https://doi.org/10.1007/s11306-025-02226-2 ER -
APA
J, S., F, D., E, P., M, P., E, C., B, C., D, W., V, D. M., A, D., & A, A. (2025). PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis.. Metabolomics : Official journal of the Metabolomic Society. https://doi.org/10.1007/s11306-025-02226-2
Source records
- pubmed · retrieved 2026-09-27T11:24:11.002Z